211 related articles for article (PubMed ID: 24114789)
21. The impact of glycosylation on monoclonal antibody conformation and stability.
Zheng K; Bantog C; Bayer R
MAbs; 2011; 3(6):568-76. PubMed ID: 22123061
[TBL] [Abstract][Full Text] [Related]
22. Influence of pH on heat-induced aggregation and degradation of therapeutic monoclonal antibodies.
Ishikawa T; Ito T; Endo R; Nakagawa K; Sawa E; Wakamatsu K
Biol Pharm Bull; 2010; 33(8):1413-7. PubMed ID: 20686240
[TBL] [Abstract][Full Text] [Related]
23. Comparison of high-throughput biophysical methods to identify stabilizing excipients for a model IgG2 monoclonal antibody: conformational stability and kinetic aggregation measurements.
Cheng W; Joshi SB; He F; Brems DN; He B; Kerwin BA; Volkin DB; Middaugh CR
J Pharm Sci; 2012 May; 101(5):1701-20. PubMed ID: 22323186
[TBL] [Abstract][Full Text] [Related]
24. Examination of thermal unfolding and aggregation profiles of a series of developable therapeutic monoclonal antibodies.
Brader ML; Estey T; Bai S; Alston RW; Lucas KK; Lantz S; Landsman P; Maloney KM
Mol Pharm; 2015 Apr; 12(4):1005-17. PubMed ID: 25687223
[TBL] [Abstract][Full Text] [Related]
25. Nonnative aggregation of an IgG1 antibody in acidic conditions: part 1. Unfolding, colloidal interactions, and formation of high-molecular-weight aggregates.
Brummitt RK; Nesta DP; Chang L; Chase SF; Laue TM; Roberts CJ
J Pharm Sci; 2011 Jun; 100(6):2087-103. PubMed ID: 21213308
[TBL] [Abstract][Full Text] [Related]
26. Effect of pH and light on aggregation and conformation of an IgG1 mAb.
Mason BD; Schöneich C; Kerwin BA
Mol Pharm; 2012 Apr; 9(4):774-90. PubMed ID: 22300012
[TBL] [Abstract][Full Text] [Related]
27. Highly concentrated monoclonal antibody solutions: direct analysis of physical structure and thermal stability.
Harn N; Allan C; Oliver C; Middaugh CR
J Pharm Sci; 2007 Mar; 96(3):532-46. PubMed ID: 17083094
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of Hydrogen Exchange Mass Spectrometry as a Stability-Indicating Method for Formulation Excipient Screening for an IgG4 Monoclonal Antibody.
Toth RT; Pace SE; Mills BJ; Joshi SB; Esfandiary R; Middaugh CR; Weis DD; Volkin DB
J Pharm Sci; 2018 Apr; 107(4):1009-1019. PubMed ID: 29269271
[TBL] [Abstract][Full Text] [Related]
29. Principles and applications of selective biophysical methods for characterization and comparability assessment of a monoclonal antibody.
Maity H; Lai Y; Srivastava A; Goldstein J
Curr Pharm Biotechnol; 2012 Aug; 13(10):2078-101. PubMed ID: 22812451
[TBL] [Abstract][Full Text] [Related]
30. Nonnative aggregation of an IgG1 antibody in acidic conditions, part 2: nucleation and growth kinetics with competing growth mechanisms.
Brummitt RK; Nesta DP; Chang L; Kroetsch AM; Roberts CJ
J Pharm Sci; 2011 Jun; 100(6):2104-19. PubMed ID: 21213307
[TBL] [Abstract][Full Text] [Related]
31. A comparison of biophysical characterization techniques in predicting monoclonal antibody stability.
Thiagarajan G; Semple A; James JK; Cheung JK; Shameem M
MAbs; 2016; 8(6):1088-97. PubMed ID: 27210456
[TBL] [Abstract][Full Text] [Related]
32. Correlating the Effects of Antimicrobial Preservatives on Conformational Stability, Aggregation Propensity, and Backbone Flexibility of an IgG1 mAb.
Arora J; Joshi SB; Middaugh CR; Weis DD; Volkin DB
J Pharm Sci; 2017 Jun; 106(6):1508-1518. PubMed ID: 28212986
[TBL] [Abstract][Full Text] [Related]
33. Correlating excipient effects on conformational and storage stability of an IgG1 monoclonal antibody with local dynamics as measured by hydrogen/deuterium-exchange mass spectrometry.
Manikwar P; Majumdar R; Hickey JM; Thakkar SV; Samra HS; Sathish HA; Bishop SM; Middaugh CR; Weis DD; Volkin DB
J Pharm Sci; 2013 Jul; 102(7):2136-51. PubMed ID: 23620222
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of a dual-wavelength size exclusion HPLC method with improved sensitivity to detect protein aggregates and its use to better characterize degradation pathways of an IgG1 monoclonal antibody.
Bond MD; Panek ME; Zhang Z; Wang D; Mehndiratta P; Zhao H; Gunton K; Ni A; Nedved ML; Burman S; Volkin DB
J Pharm Sci; 2010 Jun; 99(6):2582-97. PubMed ID: 20039394
[TBL] [Abstract][Full Text] [Related]
35. Pulse Proteolysis: An Orthogonal Tool for Protein Formulation Screening.
Iyer LK; Phanse R; Xu M; Lan W; Krause ME; Bolgar M; Hart S
J Pharm Sci; 2019 Feb; 108(2):842-850. PubMed ID: 30257193
[TBL] [Abstract][Full Text] [Related]
36. Effects of Histidine and Sucrose on the Biophysical Properties of a Monoclonal Antibody.
Baek Y; Singh N; Arunkumar A; Zydney AL
Pharm Res; 2017 Mar; 34(3):629-639. PubMed ID: 28035628
[TBL] [Abstract][Full Text] [Related]
37. Effect of pH, temperature, and salt on the stability of Escherichia coli- and Chinese hamster ovary cell-derived IgG1 Fc.
Li CH; Narhi LO; Wen J; Dimitrova M; Wen ZQ; Li J; Pollastrini J; Nguyen X; Tsuruda T; Jiang Y
Biochemistry; 2012 Dec; 51(50):10056-65. PubMed ID: 23078371
[TBL] [Abstract][Full Text] [Related]
38. Immunoglobulin dynamics, conformational fluctuations, and nonlinear elasticity and their effects on stability.
Kamerzell TJ; Ramsey JD; Middaugh CR
J Phys Chem B; 2008 Mar; 112(10):3240-50. PubMed ID: 18284232
[TBL] [Abstract][Full Text] [Related]
39. An empirical phase diagram approach to investigate conformational stability of "second-generation" functional mutants of acidic fibroblast growth factor-1.
Alsenaidy MA; Wang T; Kim JH; Joshi SB; Lee J; Blaber M; Volkin DB; Middaugh CR
Protein Sci; 2012 Mar; 21(3):418-32. PubMed ID: 22113934
[TBL] [Abstract][Full Text] [Related]
40. Conformational and Colloidal Stabilities of Isolated Constant Domains of Human Immunoglobulin G and Their Impact on Antibody Aggregation under Acidic Conditions.
Yageta S; Lauer TM; Trout BL; Honda S
Mol Pharm; 2015 May; 12(5):1443-55. PubMed ID: 25871775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
